AVALO THERAPEUTICS, INC. Repayments of Long-Term Debt
AVALO THERAPEUTICS, INC. (AVTX) reported Repayments of Long-Term Debt of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-08.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2021-03-08
- AVALO THERAPEUTICS, INC. repayments of long-term debt for the quarter ending 2020-12-31 was $0.00, a 100.00% decline year-over-year.
- AVALO THERAPEUTICS, INC. repayments of long-term debt for the quarter ending 2020-09-30 was $0.00, a 100.00% decline year-over-year.
- AVALO THERAPEUTICS, INC. repayments of long-term debt for the quarter ending 2020-06-30 was $0.00, a 100.00% decline year-over-year.
- AVALO THERAPEUTICS, INC. repayments of long-term debt for the quarter ending 2020-03-31 was $0.00, a 100.00% decline year-over-year.
- AVALO THERAPEUTICS, INC. repayments of long-term debt for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- AVALO THERAPEUTICS, INC. repayments of long-term debt for fiscal 2019 was $256.14K.
- AVALO THERAPEUTICS, INC. repayments of long-term debt for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- AVALO THERAPEUTICS, INC. repayments of long-term debt for fiscal 2017 was $2.37M, a 28.37% decline from fiscal 2016.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | $0.00 derived: sum of 2 quarters · filed 2021-03-08 | $0.00 derived: sum of 3 quarters · filed 2021-03-08 | $0.00 10-K · filed 2021-03-08 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $0.00 derived: sum of 2 quarters · filed 2020-11-09 | $0.00 10-Q · filed 2020-11-09 | $183.11K derived: sum of 4 quarters · filed 2021-03-08 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $0.00 10-Q · filed 2020-08-06 | $183.11K derived: sum of 3 quarters · filed 2021-03-08 | $207.46K derived: sum of 4 quarters · filed 2021-03-08 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-07 | $183.11K derived: sum of 2 quarters · filed 2021-03-08 | $207.46K derived: sum of 3 quarters · filed 2021-03-08 | $231.80K derived: sum of 4 quarters · filed 2021-03-08 |
| 2019-12-31 | $183.11K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | $207.46K derived: sum of 2 quarters · filed 2021-03-08 | $231.80K derived: sum of 3 quarters · filed 2021-03-08 | $256.14K 10-K · filed 2021-03-08 |
| 2019-09-30 | $24.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $48.68K derived: sum of 2 quarters · filed 2020-11-09 | $73.03K 10-Q · filed 2020-11-09 | $73.03K derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $24.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $48.68K 10-Q · filed 2020-08-06 | $48.68K derived: sum of 3 quarters · filed 2020-08-06 | $48.68K derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | $24.34K 10-Q · filed 2020-05-07 | $24.34K derived: sum of 2 quarters · filed 2020-05-07 | $24.34K derived: sum of 3 quarters · filed 2020-05-07 | $24.34K derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $0.00 derived: sum of 2 quarters · filed 2020-03-11 | $0.00 derived: sum of 3 quarters · filed 2020-03-11 | $0.00 10-K · filed 2020-03-11 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $0.00 derived: sum of 2 quarters · filed 2019-11-14 | $0.00 10-Q · filed 2019-11-14 | $0.00 derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $0.00 10-Q · filed 2019-08-08 | $0.00 derived: sum of 3 quarters · filed 2019-08-08 | $606.61K derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-09 | $0.00 derived: sum of 2 quarters · filed 2019-05-09 | $606.61K derived: sum of 3 quarters · filed 2019-05-09 | $1.50M derived: sum of 4 quarters · filed 2019-05-09 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $606.61K derived: sum of 2 quarters · filed 2019-03-18 | $1.50M derived: sum of 3 quarters · filed 2019-03-18 | $2.37M 10-K · filed 2019-03-18 |
| 2017-09-30 | $606.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $1.50M derived: sum of 2 quarters · filed 2018-11-13 | $2.37M 10-Q · filed 2018-11-13 | $3.23M derived: sum of 4 quarters · filed 2018-11-13 |
| 2017-06-30 | $892.72K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $1.77M 10-Q · filed 2018-08-09 | $2.62M derived: sum of 3 quarters · filed 2018-08-09 | $3.46M derived: sum of 4 quarters · filed 2018-08-09 |
| 2017-03-31 | $874.70K 10-Q · filed 2018-05-11 | $1.73M derived: sum of 2 quarters · filed 2018-05-11 | $2.57M derived: sum of 3 quarters · filed 2018-05-11 | $3.39M derived: sum of 4 quarters · filed 2018-05-11 |
| 2016-12-31 | $854.73K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $1.69M derived: sum of 2 quarters · filed 2018-04-02 | $2.51M derived: sum of 3 quarters · filed 2018-04-02 | $3.31M 10-K · filed 2018-04-02 |
| 2016-09-30 | $836.47K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $1.66M derived: sum of 2 quarters · filed 2017-11-07 | $2.46M 10-Q · filed 2017-11-07 | $3.25M derived: sum of 4 quarters · filed 2018-04-02 |
| 2016-06-30 | $819.12K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $1.62M 10-Q · filed 2017-08-14 | $2.41M derived: sum of 3 quarters · filed 2018-04-02 | $3.18M derived: sum of 4 quarters · filed 2018-04-02 |
| 2016-03-31 | $803.90K 10-Q · filed 2017-05-09 | $1.59M derived: sum of 2 quarters · filed 2018-04-02 | $2.36M derived: sum of 3 quarters · filed 2018-04-02 | |
| 2015-12-31 | $787.95K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $1.56M derived: sum of 2 quarters · filed 2018-04-02 | $1.81M 10-K · filed 2018-04-02 | |
| 2015-09-30 | $770.86K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $1.02M 10-Q · filed 2016-11-08 | ||
| 2015-06-30 | $252.93K 10-Q · filed 2016-08-15 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |